Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare BATS:CTRU NASDAQ:EQRR BATS:GCLN NASDAQ:MNTL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCTRUARK Transparency ETF$12.90$12.90$0.00▼$0.00N/AN/AN/A20,706 shsEQRRProShares Equities For Rising Rates ETF$59.19-2.2%$59.61$50.65▼$62.73$10.06M1.36699 shs107 shsGCLNGoldman Sachs Bloomberg Clean Energy Equity ETF$34.10$34.10$31.20▼$38.46$13.64M0.89519 shsN/AMNTLTema Neuroscience and Mental Health ETF$23.31-0.3%$22.85$19.86▼$27.66$10.26M0.99388 shs14 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCTRUARK Transparency ETF0.00%0.00%0.00%0.00%0.00%EQRRProShares Equities For Rising Rates ETF-2.87%-3.77%-1.92%+4.35%+0.32%GCLNGoldman Sachs Bloomberg Clean Energy Equity ETF0.00%0.00%0.00%0.00%-2.90%MNTLTema Neuroscience and Mental Health ETF-2.03%-0.21%+1.91%-0.50%-12.69%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCTRUARK Transparency ETFN/AN/AN/AN/AN/AN/AN/AN/AEQRRProShares Equities For Rising Rates ETFN/AN/AN/AN/AN/AN/AN/AN/AGCLNGoldman Sachs Bloomberg Clean Energy Equity ETFN/AN/AN/AN/AN/AN/AN/AN/AMNTLTema Neuroscience and Mental Health ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCTRUARK Transparency ETF 0.00N/AN/AN/AEQRRProShares Equities For Rising Rates ETF 2.70Moderate Buy$59.19N/AGCLNGoldman Sachs Bloomberg Clean Energy Equity ETF 0.00N/AN/AN/AMNTLTema Neuroscience and Mental Health ETF 2.83Moderate Buy$23.31N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCTRUARK Transparency ETFN/AN/AN/AN/AN/AN/AEQRRProShares Equities For Rising Rates ETFN/AN/AN/AN/AN/AN/AGCLNGoldman Sachs Bloomberg Clean Energy Equity ETFN/AN/AN/AN/AN/AN/AMNTLTema Neuroscience and Mental Health ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCTRUARK Transparency ETFN/AN/A0.00∞N/AN/AN/AN/AN/AEQRRProShares Equities For Rising Rates ETFN/AN/A16.51∞N/AN/AN/AN/AN/AGCLNGoldman Sachs Bloomberg Clean Energy Equity ETFN/AN/A17.47∞N/AN/AN/AN/AN/AMNTLTema Neuroscience and Mental Health ETFN/AN/A20.13∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCTRUARK Transparency ETFN/AN/AN/AN/AN/AEQRRProShares Equities For Rising Rates ETF$1.262.13%N/AN/AN/AGCLNGoldman Sachs Bloomberg Clean Energy Equity ETF$0.772.26%N/AN/AN/AMNTLTema Neuroscience and Mental Health ETF$0.251.07%N/AN/AN/ALatest GCLN, MNTL, CTRU, and EQRR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/24/2025EQRRProShares Equities For Rising Rates ETFQuarterly$0.29902.04%6/25/20256/25/20257/1/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCTRUARK Transparency ETFN/AEQRRProShares Equities For Rising Rates ETFN/AGCLNGoldman Sachs Bloomberg Clean Energy Equity ETFN/AMNTLTema Neuroscience and Mental Health ETFN/AInsider OwnershipCompanyInsider OwnershipCTRUARK Transparency ETFN/AEQRRProShares Equities For Rising Rates ETFN/AGCLNGoldman Sachs Bloomberg Clean Energy Equity ETFN/AMNTLTema Neuroscience and Mental Health ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCTRUARK Transparency ETFN/AN/AN/ANot OptionableEQRRProShares Equities For Rising Rates ETFN/A170,000N/ANot OptionableGCLNGoldman Sachs Bloomberg Clean Energy Equity ETFN/A400,000N/ANot OptionableMNTLTema Neuroscience and Mental Health ETFN/A440,000N/AN/AGCLN, MNTL, CTRU, and EQRR HeadlinesRecent News About These CompaniesHone Your Biotech Allocation in Neuroscience ETF MNTLDecember 12, 2024 | etftrends.comEMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military Spend3 Short Squeeze Candidates With Big Catalysts on the HorizonBy Dan Schmidt | July 25, 2025View 3 Short Squeeze Candidates With Big Catalysts on the HorizonHow a Government Loan Changes the Game for Plug PowerBy Jeffrey Neal Johnson | July 4, 2025View How a Government Loan Changes the Game for Plug PowerAmerica Wants Drone Dominance: Are These Stocks Ready to Soar?By Chris Markoch | July 20, 2025View America Wants Drone Dominance: Are These Stocks Ready to Soar?Best Prime Day Ever? Here Are the Prime Winners Riding the WaveBy Thomas Hughes | July 14, 2025View Best Prime Day Ever? Here Are the Prime Winners Riding the WaveGCLN, MNTL, CTRU, and EQRR Company DescriptionsARK Transparency ETF BATS:CTRU$12.90 0.00 (0.00%) As of 07/26/2022ProShares Equities For Rising Rates ETF NASDAQ:EQRR$59.19 -1.36 (-2.25%) Closing price 08/1/2025 10:19 AM EasternExtended Trading$59.30 +0.11 (+0.19%) As of 08/1/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The ProShares Equities for Rising Rates ETF (EQRR) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of 50 US-listed large-cap stocks that are anticipated to perform favorably during periods of rising interest rates. EQRR was launched on Jul 24, 2017 and is managed by ProShares.Goldman Sachs Bloomberg Clean Energy Equity ETF BATS:GCLN$34.10 0.00 (0.00%) As of 08/1/2025The Goldman Sachs Bloomberg Clean Energy Equity ETF (GCLN) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks an index of global companies expected to have significant impact on the clean energy industry. Holdings are market-cap weighted and tilted towards those with more relevance to clean energy and decarbonization. GCLN was launched on Feb 8, 2022 and is managed by Goldman Sachs.Tema Neuroscience and Mental Health ETF NASDAQ:MNTL$23.31 -0.06 (-0.25%) Closing price 08/1/2025 12:46 PM EasternExtended Trading$23.31 0.00 (0.00%) As of 08/1/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Tema Neuroscience and Mental Health ETF (MNTL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, concentrating on companies engaged in addressing disorders of the central nervous system and mental health worldwide. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. MNTL was launched on Jan 22, 2024 and is issued by Tema. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Why Bloom Energy Stock Could Break to New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
